event tracking

Stephen Baylin

25 results.

April 3, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

Hand pouring into measuring container in science lab
December 20, 2018 Three Van Andel Research Institute scientists named to list of most cited researchers in the world

GRAND RAPIDS, Mich. (Dec. 21, 2018) — Van Andel Research Institute-affiliated scientists Peter W. Laird, Ph.D., Stephen B. Baylin, M.D., and H. Eric Xu, Ph.D.,…

May 8, 2018 Fighting cancer is a team effort

By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team Four years ago, we embarked…

December 20, 2017 10 highlights: A look back at 2017

With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…

November 29, 2017 Clinical trial investigates possible triple threat for lung cancer

A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other cancer type and…

VAI DEFAULT HEADER
October 11, 2017 A Catalyst for combating cancer

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…

October 11, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…